Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic ...
A breast lump is the most common and recognized symptom of breast cancer, according to a 2023 study published in Preventive ...
Women and younger Americans are being diagnosed with cancer more than ever before, according to a new report published by ...
The US Food and Drug Administration (FDA) has granted breakthrough device designation to PreludeDx's DCISionRT test, a risk ...
Drinking damages the body's DNA, leading to cancerous tissue growth. The safest option is to avoid consumption, experts say.
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...
Hundreds of FDA-approved drugs tested directly on a patient’s tumor sample. Could this be a gamechanger for cancer management ...
Dr. Victoria Forte has been appointed chief of the Division of Hematology/Oncology, Cancer Service Line director, and ...
The American Cancer Society (ACS) today released Cancer Statistics, 2025, the organization's annual report on cancer facts and trends. The new findings show the cancer mortality rate declined by 34% ...
Research shows that people with a certain body shape face a higher risk of serious health problems compared to their ...
MediBeacon Inc. today announced the U.S. Food and Drug Administration (FDA) has approved the MediBeacon® TGFR for the assessment of kidney function in patients with normal or impaired renal function.
In this contributed article, American author and investigative journalist Nina Teicholz looks into the process followed by a ...